Microscopic Hematuria
Introduction
Microscopic hematuria describes the presence of red blood cells in the urine in amounts too small to be visible without a microscope. It is typically identified during a routine urinalysis when microscopic examination reveals an elevated number of red blood cells per high-power field in a urine sample. This common finding can be transient or persistent, signaling a variety of underlying health conditions.
The biological basis of microscopic hematuria involves the compromise of the integrity of the urinary system, allowing red blood cells to enter the urine stream. The kidneys, ureters, bladder, and urethra work together to filter blood and excrete waste while retaining blood components like red blood cells. Disruption to this system, whether due to inflammation, infection, physical trauma, or structural abnormalities, can lead to the leakage of red blood cells. Causes are diverse, ranging from benign factors like intense physical activity or urinary tract infections to more serious conditions such as kidney stones, various forms of kidney disease, or malignancies within the urinary tract.
Clinically, microscopic hematuria is a significant finding because it often serves as an early indicator for a range of medical conditions, some of which require prompt diagnosis and treatment. Its detection necessitates further diagnostic evaluation to pinpoint the specific cause, which may include additional urine and blood tests, imaging studies, and potentially more invasive procedures like cystoscopy or kidney biopsy. Early identification and management are critical for preventing the progression of kidney disease, addressing complications from urinary stones, or improving prognosis in cases of cancer.
From a social standpoint, the discovery of microscopic hematuria can be a source of anxiety for individuals, often initiating a diagnostic process that can be both extensive and emotionally challenging. Its role in public health is underscored by its occasional detection during routine health screenings, highlighting its importance in the early detection of potentially serious diseases within the broader population. A comprehensive understanding of the causes and implications of microscopic hematuria is therefore essential for both healthcare professionals and the public to ensure appropriate follow-up and intervention, contributing to improved health outcomes and overall well-being.
Methodological and Phenotypic Characterization Constraints
The study's reliance on urine dipstick measurements, obtained within a clinical setting, introduces inherent limitations in the precise characterization of microscopic hematuria. Dipstick tests offer semi-quantitative results, categorizing the trait into broad groups such as '+' or '++ or greater' versus negative controls, and explicitly excluding 'trace' results. [1] This categorical simplification of a complex biological continuum may obscure subtle genetic effects or lead to misclassification, potentially reducing the statistical power to detect associations with variants influencing less pronounced levels of hematuria. Furthermore, the clinical origin of these measurements suggests a cohort that may not be fully representative of a random sample of healthy individuals, potentially leading to cohort bias where genetic associations might differ in a truly healthy population. [1] This selective ascertainment could influence the observed effect sizes and the interpretation of variant pathogenicity, particularly for conditions that result in elevated urinary biomarker levels.
Generalizability and Replication Challenges
A significant limitation of the research is the lack of independent replication in diverse populations. While the study benefits from a large sample size, its findings are primarily derived from a population that is likely of European ancestry. [1] The absence of replication in other ethnic groups means the generalizability of these genetic associations to broader global populations remains uncertain. [1] Although common variants are often expected to show similar associations across European populations, genetic architectures can vary substantially between different ancestries due to differences in allele frequencies, linkage disequilibrium patterns, and environmental exposures. [1] Therefore, the identified variants may have different penetrance, effect sizes, or even be entirely absent in non-European populations, necessitating further studies to validate these findings and explore their consistency across diverse genetic backgrounds. [2]
Unaccounted Genetic and Environmental Complexity
Despite rigorous statistical adjustments for factors such as sex, age, and county, and the application of methods like LD score regression to account for relatedness and stratification [1] the study acknowledges the potential influence of unmeasured environmental or gene-environment confounders. For example, while no sex-specific difference was detected for the investigated variants, menstruation is recognized as a common cause of hematuria in women [3] suggesting that other non-genetic factors could still influence the overall prevalence or presentation of the trait in the broader population. The complex etiology of hematuria, which can range from benign familial conditions like thin basement membrane nephropathy to more severe disorders, implies that the identified genetic variants represent only a part of the overall genetic architecture. [1] This highlights remaining knowledge gaps in understanding the full spectrum of genetic and environmental interactions contributing to microscopic hematuria, underscoring the need for continued research to fully elucidate its underlying mechanisms.
Variants
Genetic variations play a crucial role in influencing an individual's susceptibility to various health conditions, including microscopic hematuria, which is the presence of red blood cells in the urine not visible to the naked eye. These variants can affect genes involved in immune regulation, structural integrity of kidney filtration barriers, cellular dynamics, and blood cell function.
Variants near TGFB1 and CCDC97 are associated with immune responses and tissue remodeling within the kidney. For example, the rs56254331 variant is linked to a decreased risk of hematuria, an effect that is thought to be mediated by its association with higher expression of the TGFB1 gene. [1] TGFB1 encodes transforming growth factor beta 1, a cytokine known for its role in cell growth, differentiation, and immune response, often acting as a pro-inflammatory mediator. [1] Its involvement in Camurati–Engelmann disease, a rare genetic disorder, further highlights its importance in tissue development and regulation. [1] The interplay of immune factors regulated by genes like TGFB1 can significantly influence renal health and the delicate balance required to prevent conditions like hematuria.
The structural integrity of the kidney's filtration system is largely dependent on collagen proteins, as exemplified by the COL4A2 gene and its close relatives. While rs2149067 in COL4A2 is a focus, other members of the collagen type IV family, such as COL4A3, are well-established for their critical role in forming the glomerular basement membrane (GBM), a key component of the kidney's filtration barrier. [1] Mutations and variants in these genes, including a significant 2.5 kb deletion or the Gly695Arg missense variant in COL4A3, can disrupt GBM structure, leading to conditions like familial benign hematuria or the more severe Alport syndrome, both characterized by persistent hematuria and sometimes proteinuria. [1] These findings underscore how variants affecting collagen synthesis and assembly directly impact the kidney's ability to retain blood cells, thereby preventing hematuria.
Other variants, such as rs871841 in ARHGEF15, rs1436428 in MMP15, and rs11631778 and rs1441358 in THSD4, influence cellular dynamics and tissue remodeling, processes crucial for maintaining kidney function. ARHGEF15 is involved in regulating cell shape and adhesion, which are vital for specialized kidney cells like podocytes that form part of the filtration barrier. MMP15, a matrix metallopeptidase, plays a role in breaking down and remodeling the extracellular matrix, a process that must be tightly controlled to prevent damage to delicate kidney structures. THSD4 contributes to cell adhesion and tissue integrity, and variants here could impact the stability of renal tissues. Furthermore, the rs334 variant in the HBB gene, known for its association with sickle cell trait, can lead to hematuria due to the abnormal shape of red blood cells, which can damage kidney tissue and impair its function, causing conditions like renal papillary necrosis.
Variants in genes like SORL1 (rs1944694), PLLP (rs948705), RHBDD1 (rs13029283), and the region involving EIF3EP2 and GCG (rs75166367) also contribute to cellular homeostasis and protein processing, indirectly affecting kidney health. SORL1 is involved in protein sorting and endocytosis, critical for the reabsorption functions of renal tubules. PLLP plays a role in membrane organization and vesicle trafficking, which are fundamental to cell communication and nutrient exchange within kidney cells. RHBDD1 is a protease involved in protein degradation and cellular stress responses, potentially impacting cell survival and function under physiological stress. While EIF3EP2 is a pseudogene, and GCG primarily functions in glucose metabolism, genetic variations in these regions may have regulatory effects or be linked to metabolic disorders that indirectly influence kidney function and contribute to hematuria.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs56254331 | CCDC97, TGFB1 | blood protein amount diastolic blood pressure urinary albumin to creatinine ratio IGA glomerulonephritis high density lipoprotein cholesterol measurement |
| rs1944694 | SORL1 - RNU6-256P | microscopic hematuria |
| rs2149067 | COL4A2 | microscopic hematuria |
| rs948705 | PLLP - RPL23AP91 | red blood cell density hematocrit hemoglobin measurement microscopic hematuria |
| rs871841 | ARHGEF15 | total cholesterol measurement BMI-adjusted waist-hip ratio low density lipoprotein cholesterol measurement hematocrit hemoglobin measurement |
| rs13029283 | RHBDD1 | microscopic hematuria |
| rs75166367 | EIF3EP2 - GCG | CLEC14A/EPHB4 protein level ratio in blood basigin measurement CD27 antigen measurement tgf-beta receptor type-2 measurement level of trans-Golgi network integral membrane protein 2 in blood |
| rs1436426 | MMP15 | microscopic hematuria |
| rs11631778 rs1441358 |
THSD4 | diastolic blood pressure asthma microscopic hematuria |
| rs334 | HBB | glomerular filtration rate urinary albumin to creatinine ratio HbA1c measurement hemolysis urate measurement |
Defining Microscopic Hematuria and Diagnostic Criteria
Microscopic hematuria is precisely defined by the presence of red blood cells in urine that are detectable only under a microscope or through chemical tests, rather than being visible to the naked eye. Operationally, in research settings, cases of hematuria are identified by at least one positive urine dipstick reading, whereas controls are individuals with only negative urine dipstick readings. [1] This diagnostic approach relies on the chemical detection of heme within red blood cells, which is a common and practical screening method in clinical settings. [3] Trace results on urine dipstick tests are generally not included in analytical definitions for case categorization. [1]
Classification Systems and Severity Grading
Hematuria can be classified into different categories based on its severity, typically assessed by the intensity of the urine dipstick reaction. A "mild" classification is assigned when at least one urine dipstick reading shows a '+' result without any greater readings, indicating a lower concentration of red blood cells. [1] Conversely, "moderate/severe" hematuria is diagnosed when at least one urine dipstick reading is '++' or greater, signifying a more substantial presence of blood in the urine. [1] This categorical classification, differentiating between mild and moderate/severe forms, is crucial for both clinical assessment and research, allowing for the investigation of distinct genetic associations or clinical outcomes related to varying levels of hematuria.
Etiological Context and Associated Terminology
The presence of microscopic hematuria can be indicative of several underlying conditions, and its terminology often relates to these potential causes. Common causes include urinary tract infections (UTI), kidney stones, and urinary tract malignancies. [1] In women, menstruation is also a recognized cause of hematuria. [3] Genetically, mutations in the COL4A3 gene are associated with specific forms of hematuria, including autosomal dominant benign familial hematuria, which is also known as thin basement membrane nephropathy. [1] These COL4A3 mutations can also lead to more severe conditions such as autosomal dominant Alport syndrome, highlighting the diverse etiologies and the importance of accurate classification and terminology in guiding clinical management and genetic counseling. [1]
Detection and Classification of Microscopic Hematuria
Microscopic hematuria is primarily a clinical sign rather than a symptomatic condition, often detected incidentally during routine urinalysis. [1] Patients typically do not present with visible blood in the urine, distinguishing it from gross hematuria. The primary method for detection involves urine dipstick readings, which can categorize the presence and severity of hematuria. A positive dipstick reading indicates the presence of blood, with classifications ranging from "mild" (a single '+' reading) to "moderate/severe" (a '++' or greater reading), providing an objective measure of the extent of hematuria. [1] This method allows for a standardized assessment across individuals, although its clinical context can influence its diagnostic interpretation. [1]
Clinical Phenotypes and Genetic Associations
Microscopic hematuria exhibits phenotypic diversity, ranging from isolated findings to presentations accompanied by other urinary abnormalities, notably proteinuria. While menstruation can be a cause of hematuria in women [3] genetic studies have indicated that specific genetic variants associated with hematuria may not show significant differences in effect between sexes. [1] Some genetic signals specifically associate with moderate to severe forms of hematuria, highlighting the spectrum of severity that can be genetically predisposed. [1] Key genetic associations include a 2.5 kb deletion and a rare missense variant (Gly695Arg) in the COL4A3 gene, both of which are linked to an increased risk of hematuria and sometimes proteinuria. [1] Mutations in COL4A3, which encodes a major component of glomerular basement membranes, are known to cause conditions such as autosomal dominant benign familial hematuria and autosomal dominant Alport syndrome. [1] These genetic findings offer insights into the underlying mechanisms, particularly in cases of persistent or unexplained microscopic hematuria.
Differential Considerations and Diagnostic Significance
When microscopic hematuria is detected, it prompts investigation into various potential etiologies. While urinary tract infections (UTIs), kidney stones, and urinary tract malignancies are frequently considered in the differential diagnosis, it is important to note that certain genetic signals identified for hematuria in studies do not strongly correlate with UTIs, kidney issues, or known cancer-associated variants, suggesting distinct pathways for genetically mediated hematuria. [1] The presence of specific genetic variants, such as those in COL4A3, can be highly diagnostically significant, indicating conditions like benign familial hematuria or Alport syndrome, which may also present with minimal proteinuria. [1] These genetic insights help refine the diagnostic process, guiding further clinical management and distinguishing hereditary forms of hematuria from other acquired causes. The distinction between mild and moderate/severe hematuria, as assessed by dipstick, can also be a prognostic indicator, as some genetic predispositions are exclusively linked to the more severe presentations. [1]
Causes of Microscopic Hematuria
Microscopic hematuria, the presence of blood in urine detectable only by microscopic examination or chemical testing, arises from a complex interplay of genetic predispositions, environmental exposures, and various physiological and comorbid conditions. Understanding these diverse causal factors is crucial for accurate diagnosis and management.
Genetic Predisposition and Inherited Conditions
An individual's genetic makeup significantly influences their susceptibility to microscopic hematuria, with both rare and common sequence variants contributing to risk. Research has identified specific genetic loci associated with an increased likelihood of hematuria, including variants within COL4A3, 2q36, HLA-C, and TGFB1 . A critical structural component of the GBM is type IV collagen, which forms heterotrimeric molecules from six different alpha chains, with those encoded by the COL4A3 gene being particularly important. [1] Maintaining the integrity of this intricate membrane is crucial for proper kidney function, and any compromise can lead to microscopic hematuria, characterized by the presence of red blood cells in the urine. [1]
Genetic Determinants of Glomerular Health
Genetic variations play a significant role in the structural integrity of the glomeruli and, consequently, in the occurrence of microscopic hematuria. Mutations in the COL4A3 gene, for example, are strongly associated with an increased risk of this condition. [1] One such variant is a rare 2475 bp deletion-insertion within COL4A3, spanning exons 16 and 17, which leads to a substantial in-frame deletion in the gene product (Gly289 Lys330del). [1] Another identified variant is the missense mutation Gly695Arg, represented by rs200287952, which also associates with hematuria and is classified as 'likely pathogenic'. [1] These genetic alterations can compromise the stability and function of type IV collagen in the GBM, leading to conditions like autosomal dominant benign familial hematuria, also known as thin basement membrane nephropathy, and the more severe autosomal dominant Alport syndrome. [1] While benign familial hematuria generally has a favorable course, sometimes accompanied by minimal proteinuria, Alport syndrome often progresses to chronic kidney disease. [1]
Cellular and Molecular Responses to Renal Injury
Microscopic hematuria can also arise from complex cellular and molecular pathways involved in the body's response to injury and inflammation within the renal system. For instance, the transforming growth factor beta 1 (TGFB1) signaling pathway is implicated, with a genetic variant that decreases hematuria risk being associated with higher TGFB1 expression. [1] TGFB1 is a key cytokine with diverse roles in both promoting and suppressing inflammatory responses, and it is crucial for tissue repair and immune regulation. [4] Furthermore, processes related to hemostasis, such as platelet adhesion to exposed collagen, are fundamental responses to blood vessel wall injury, which can be a direct cause of hematuria. [5] Collagens are abundant in the vascular epithelia, and their exposure after injury triggers the initial steps of platelet activation and the formation of a clot. [5] The extracellular matrix pathway and general cytokine signaling within the immune system are also broadly linked to hematuria, highlighting the intricate biological mechanisms contributing to its pathogenesis. [5]
Pathophysiological Context and Systemic Implications
Microscopic hematuria serves as an important clinical indicator, often signaling underlying disruptions in the normal functioning of the kidneys or urinary tract. [6] While common causes such as urinary tract infections, kidney stones, or urinary tract malignancies are typically investigated, specific genetic factors can lead to hematuria independently of these conditions. [1] The clinical significance of hematuria varies greatly, ranging from benign familial hematuria, which is generally considered harmless, to severe progressive disorders like Alport syndrome. [1] The interplay between inherited genetic variations, such as those impacting COL4A3, and the dynamic cellular and molecular responses to renal stress or injury ultimately dictates the presence and clinical course of microscopic hematuria, making it a critical biomarker for assessing kidney health. [1]
Glomerular Structural Integrity and Filtration Barrier Dysregulation
Microscopic hematuria often originates from structural compromises within the kidney's filtration apparatus, particularly the glomerular basement membrane (GBM). The COL4A3 gene, encoding one of the alpha chains of type IV collagen, is crucial for forming the heterotrimeric collagen molecules that are the primary structural components of the GBM. [7] Pathogenic variants in COL4A3, such as a 2.5 kb deletion spanning exons 16 and 17 or a Gly695Arg missense variant, can severely impair the integrity of the GBM, leading to conditions like autosomal dominant benign familial hematuria and Alport syndrome. [7] These genetic alterations disrupt the finely tuned molecular architecture of the glomerulus, allowing red blood cells to leak into the urine.
Beyond the glomerulus, the proper function of renal tubules in reabsorbing filtered proteins is also vital for maintaining kidney health, with genes like LRP2 and CUBN playing roles in proximal tubule protein reabsorption. [8] While primarily associated with proteinuria, LRP2 has also shown an association with estimated glomerular filtration rate (eGFR), suggesting its broader involvement in glomerular function. [7] Dysregulation of these reabsorptive mechanisms, although not directly causing hematuria, highlights the interconnectedness of renal physiological processes where compromised structural or functional integrity at any level can contribute to overall kidney dysfunction.
Immune and Inflammatory Signaling Pathways
Inflammation and immune responses represent significant pathways contributing to microscopic hematuria. The major histocompatibility complex (MHC) class I gene HLA-C has been associated with hematuria, indicating a potential role for immune recognition and cellular immunity in its pathogenesis. [7] Furthermore, the transforming growth factor beta 1 (TGFB1) gene, a key regulator of cell growth, differentiation, and immune function, is another signal associating with hematuria. [7] TGF-β, along with other cytokines such as IL-10 and IL-22, orchestrates complex anti-inflammatory and pro-inflammatory signaling cascades within tissues, including the kidney. [4]
These intricate signaling pathways involve receptor activation, intracellular cascades, and transcription factor regulation, collectively influencing the immune cell infiltration and inflammatory milieu within renal tissues. [4] Dysregulation of these cytokine signaling pathways can lead to chronic inflammation, tissue damage, and increased vascular permeability within the kidney, thereby contributing to the extravasation of red blood cells and the manifestation of hematuria. [5] The interplay between these immune components underscores a systems-level integration where network interactions can lead to emergent properties of disease.
Hemostatic Mechanisms and Vascular Integrity
The body's hemostatic mechanisms are critical in preventing blood loss, and their dysregulation can directly lead to hematuria. A primary mechanism involves platelet adhesion to exposed collagen, which is the initial step in forming a platelet plug in response to blood vessel injury. [5] Collagens are not only structural components of the GBM but are also abundant in vascular epithelia, providing crucial binding sites for platelet-expressed collagen-binding proteins. [5] Any compromise to vascular integrity, whether due to inflammation, direct trauma, or underlying structural defects, can expose these subendothelial collagens.
This exposure triggers a cascade of signaling events on platelet surfaces, leading to their activation, adhesion, and aggregation, aiming to seal the vessel breach. [5] However, if the injury is persistent or the hemostatic response is inadequate, blood can continue to escape, manifesting as hematuria. The extracellular matrix pathway, which includes collagens and other structural proteins, is also broadly associated with hematuria, highlighting its foundational role in maintaining vascular and tissue integrity. [5]
Genetic Regulation and Systems-Level Dysregulation
Microscopic hematuria often arises from complex interactions between genetic predisposition and environmental factors, manifesting through dysregulation of fundamental cellular processes. Genetic variants, ranging from single nucleotide polymorphisms to large structural changes like the 2.5 kb deletion in COL4A3, can alter gene expression and protein function, profoundly impacting renal physiology. [7] These genetic changes initiate cascades of pathway dysregulation, where altered protein modifications or changes in regulatory feedback loops contribute to the overall disease phenotype.
At a systems level, various pathways exhibit crosstalk and network interactions that are hierarchically regulated. For example, the association of both the extracellular matrix pathway and cytokine signaling in the immune system with hematuria suggests a significant interplay between structural integrity and inflammatory responses. [5] Such complex interactions underscore that hematuria is often an emergent property of multiple interconnected molecular and cellular dysfunctions, rather than a single isolated pathway defect, offering potential therapeutic targets by understanding these integrated regulatory mechanisms.
Identification and Initial Assessment
Microscopic hematuria is clinically identified by the presence of blood in urine, primarily detected through urine dipstick readings. [7] This diagnostic utility allows for the initial identification of individuals who may require further evaluation. The severity of microscopic hematuria can be classified as mild, indicated by at least one positive dipstick reading, or moderate/severe, characterized by readings of ++ or greater. [7] This initial stratification provides an early indication of the extent of hematuria, which is crucial for guiding subsequent diagnostic steps and risk assessment in patient care. [7]
Association with Urinary Tract Infections
Microscopic hematuria can be an indicator or an accompanying feature of other urinary conditions, most notably urinary tract infections (UTIs). [7] In a clinical context, UTIs are identified by positive readings for both nitrites, which suggest the presence of nitrate-reducing bacteria, and leukocyte esterase, indicating neutrophils, occurring on the same day. [7] Recognizing this association is important for comprehensive patient care, as the presence of hematuria alongside these markers can prompt clinicians to investigate for active infection, influencing diagnostic pathways and potential treatment strategies. [7]
Influence of Urine Characteristics on Assessment
Beyond infection, other urine characteristics, such as pH, play a role in the comprehensive assessment of individuals with microscopic hematuria. [7] Specifically, cases may be associated with low urine pH, defined as a reading of 5.0 or below. [7] Considering urine pH alongside the detection of hematuria provides additional clinical context, which can be valuable in narrowing down potential etiologies or contributing factors and informing subsequent diagnostic or management approaches for the patient. [7]
Frequently Asked Questions About Microscopic Hematuria
These questions address the most important and specific aspects of microscopic hematuria based on current genetic research.
1. I feel fine, why did my doctor find blood in my urine?
It's common for microscopic hematuria to have no visible symptoms, which is why it's often found during routine tests. This condition means red blood cells are in your urine in amounts too small to see. While it can be transient or benign, it's a significant finding that prompts further evaluation to rule out underlying issues like kidney stones, infections, or other conditions. Your doctor will want to investigate to find the cause.
2. Can my intense workouts cause blood in my urine?
Yes, intense physical activity is a recognized benign factor that can temporarily lead to microscopic hematuria. This happens because strenuous exercise can cause minor stress to your urinary system. However, if it persists or you have other symptoms, it's important to discuss it with your doctor to ensure there isn't a more serious underlying cause.
3. Does blood in the urine run in my family?
Yes, there can be a genetic component to microscopic hematuria, meaning it can run in families. Genetic variations in genes involved in kidney structure or immune regulation, like those near TGFB1 or COL4A2, can influence your susceptibility. While genetics play a role, many other factors, both environmental and lifestyle, also contribute.
4. Can my period cause blood in my urine test?
Yes, menstruation is a common non-genetic factor that can lead to the detection of red blood cells in a urine sample, potentially causing a false positive for microscopic hematuria. It's important to inform your doctor if you are menstruating when providing a urine sample. This helps them accurately interpret your test results and avoid unnecessary investigations.
5. Does my risk of getting blood in urine increase with age?
The article highlights that age is a factor often considered in studies, implying its relevance to microscopic hematuria. Many underlying conditions that cause hematuria, such as kidney disease or malignancies, can become more prevalent with age. Therefore, while not solely genetic, age can be a contributing factor to the overall likelihood of detection and the need for evaluation.
6. Does my family background affect my risk for blood in urine?
Yes, your family background, particularly your ethnic ancestry, can influence your risk. Genetic architectures and allele frequencies can vary significantly across different populations. Research on genetic variants associated with microscopic hematuria has primarily focused on populations of European ancestry, meaning these findings might differ in other ethnic groups. Further studies are needed to understand these differences.
7. If blood is found once, does that mean I have a serious problem?
Not necessarily. Microscopic hematuria can be a transient finding, sometimes due to benign causes like intense exercise or a urinary tract infection. However, it's also a crucial early indicator for more serious conditions like kidney stones, kidney disease, or even cancer. Your doctor will likely recommend further diagnostic evaluation to determine the specific cause and ensure appropriate follow-up.
8. Can I do anything to prevent blood in my urine?
While some causes of microscopic hematuria are genetic or unpreventable, you can reduce your risk for certain underlying conditions. For example, staying hydrated can help prevent kidney stones, and practicing good hygiene can reduce the risk of urinary tract infections. Addressing any identified underlying health issues promptly is also key to preventing recurrence or progression.
9. Would a genetic test tell me my personal risk for this?
A genetic test could identify specific variants, such as rs56254331 near TGFB1, that are associated with a decreased or increased risk of microscopic hematuria. However, these variants represent only a part of the overall genetic architecture. The full picture involves complex interactions with your environment and other unmeasured factors, so a genetic test provides only one piece of the puzzle.
10. Why do some people get blood in urine, but others don't?
It's a combination of genetics and environmental factors. Some individuals have genetic variations that influence the structural integrity of their kidneys or their immune response, making them more susceptible. For example, variations in genes like COL4A2 affect kidney filtration. Others might experience it due to infections, trauma, or intense physical activity, while some people are simply less prone to these issues.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Benonisdottir S, Kristjansson RP, Oddsson A, et al. "Sequence variants associating with urinary biomarkers." Hum Mol Genet, 2019.
[2] Green, H. D., et al. "Genome-wide association study of microscopic colitis in the UK Biobank confirms immune-related pathogenesis." Journal of Crohn's and Colitis, 2019.
[3] Simerville, J.A., et al. "Urinalysis: a comprehensive review." American Family Physician, vol. 71, no. 6, 2005, pp. 1153–1162.
[4] Sanjabi, S., et al. "Anti-inflammatory and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunity." Current Opinion in Pharmacology, vol. 9, no. 4, 2009.
[5] Kerns SL, et al. "Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy." J Natl Cancer Inst, 2019.
[6] Tesch, G.H. "Review: Serum and urine biomarkers of kidney disease: a pathophysiological perspective." Nephrology, vol. 15, no. 6, 2010.
[7] Benonisdottir, S. "Sequence variants associating with urinary biomarkers." Human Molecular Genetics, vol. 27, no. 24, 2018.
[8] Nielsen, R., Christensen, E.I., and Birn, H. "Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease." Kidney International, vol. 89, 2016, pp. 58–67.